I'm a grad student [redacted] with projects and papers that have focused on drug design and medchem rather than the more "hardcore" total synthesis and methodology work. Do you think I really have any chance of getting a pharma job in the current job market?Great question. Since I'm not a medicinal chemist, I thought I would ask Derek Lowe. Here's our (very brief) conversation via Twitter.
I've been asking various people in the industry and out and answers seem to vary wildly, some of the variability I'm sure is what year they are using as their reference in their mind. Some say yes, though with much better odds at a smaller startup company. Others say a flat out no, that you must have a postdoc, and the bigger the name brand lab you can get into the better (preferably in total synthesis or methodology).
Me: is the received wisdom still graduate students in medicinal chemistry programs are at relative disadvantage in hiring?
DL: I think there's still some of that out there, but I think that it's gradually improved. Would be interested in more takes on it!I suspect the number of data points is relatively small, so I can't imagine that there is definitive information out there. In lieu of that, I'd love to hear reader thoughts on this question, especially in reference to your company's recent entry-level Ph.D. hires.